ENTA
Enanta Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.08
+0.43%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+24.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 10, 2026 | Rottinghaus Scott T. · officer: Chief Medical Officer | F-InKind | 1,467 | $13 |
| Mar 13, 2026 | CARTER BRUCE L A · director | A-Award | 20,000 | $14 |
| Mar 13, 2026 | FOLETTA MARK G · director | A-Award | 20,000 | $14 |
| Mar 13, 2026 | Peterson Kristine · director | A-Award | 20,000 | $14 |
| Mar 13, 2026 | Vance Terry · director | A-Award | 20,000 | $14 |
| Mar 13, 2026 | Russell Lesley · director | A-Award | 20,000 | $14 |
| Mar 13, 2026 | Hata Yujiro S · director | A-Award | 20,000 | $14 |
| Feb 13, 2026 | Luly Jay R. · director, officer: President and CEO | A-Award | 4,800 | $0.00 |
| Feb 13, 2026 | Luu Brendan · officer: Chief Business Officer | A-Award | 1,575 | $0.00 |
| Feb 13, 2026 | Kowalsky Matthew Paul · officer: Chief Legal Officer | A-Award | 1,318 | $0.00 |
| Feb 13, 2026 | Luly Jay R. · director, officer: President and CEO | A-Award | 15,200 | $0.00 |
| Feb 13, 2026 | Or Yat Sun · officer: Chief Scientific Officer | F-InKind | 3,413 | $14 |
| Feb 13, 2026 | Kieffer Tara Lynn · officer: Chief Product Strategy Officer | A-Award | 4,987 | $0.00 |
| Feb 13, 2026 | Or Yat Sun · officer: Chief Scientific Officer | A-Award | 1,650 | $0.00 |
| Feb 13, 2026 | Rottinghaus Scott T. · officer: Chief Medical Officer | F-InKind | 3,413 | $14 |
| Feb 13, 2026 | Rottinghaus Scott T. · officer: Chief Medical Officer | A-Award | 5,225 | $0.00 |
| Feb 13, 2026 | Or Yat Sun · officer: Chief Scientific Officer | A-Award | 5,225 | $0.00 |
| Feb 13, 2026 | Luu Brendan · officer: Chief Business Officer | F-InKind | 3,257 | $14 |
| Feb 13, 2026 | Kieffer Tara Lynn · officer: Chief Product Strategy Officer | A-Award | 1,575 | $0.00 |
| Feb 13, 2026 | Kowalsky Matthew Paul · officer: Chief Legal Officer | A-Award | 4,175 | $0.00 |
| Feb 13, 2026 | Luly Jay R. · director, officer: President and CEO | F-InKind | 6,155 | $14 |
| Feb 13, 2026 | Kieffer Tara Lynn · officer: Chief Product Strategy Officer | F-InKind | 3,257 | $14 |
| Feb 13, 2026 | Luu Brendan · officer: Chief Business Officer | A-Award | 4,987 | $0.00 |
| Feb 13, 2026 | Kowalsky Matthew Paul · officer: Chief Legal Officer | F-InKind | 1,902 | $14 |
| Feb 13, 2026 | Rottinghaus Scott T. · officer: Chief Medical Officer | A-Award | 1,650 | $0.00 |
| Dec 5, 2025 | Luly Jay R. · director, officer: President and CEO | Sale | 4,743 | $14 |
| Dec 5, 2025 | Or Yat Sun · officer: Chief Scientific Officer | Sale | 2,390 | $14 |
| Dec 5, 2025 | Capps Kathleen S. · officer: See Remarks | Sale | 323 | $14 |
| Dec 5, 2025 | Luu Brendan · officer: Chief Business Officer | Sale | 1,394 | $14 |
| Dec 5, 2025 | Rottinghaus Scott T. · officer: Chief Medical Officer | Sale | 798 | $14 |
Institutional positioning
13F filings over the trailing two quarters
New 39Increased 93Reduced 75Sold out 21
| Filer | Action | Shares | Filed |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | Increased | 3,784,055 | May 18, 2026 |
| Jupiter Topco LLC | New Position | 3,654,920 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 3,244,448 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 3,103,768 | May 13, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Increased | 2,871,862 | May 15, 2026 |
| KRENSAVAGE ASSET MANAGEMENT, LLC | Increased | 2,866,138 | May 15, 2026 |
| Krensavage Asset Management, LLC | Unchanged | 2,866,138 | Aug 14, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Reduced | 2,418,202 | Aug 14, 2026 |
| DEEP TRACK CAPITAL, LP | Unchanged | 1,956,867 | May 15, 2026 |
| Deep Track Capital, LP | Reduced | 1,444,167 | Aug 14, 2026 |
| ADAR1 Capital Management, LLC | Increased | 1,344,510 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 1,211,769 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,178,049 | May 15, 2026 |
| Spruce Street Capital LP | Increased | 1,088,731 | Aug 13, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 1,078,317 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 10, 2026